Table 2.
30-day adverse events.
All n = 166 | |
---|---|
Reinfarction | 8 (5%) |
Definite stent thrombosis | 3 (2%) |
Ischemic stroke | 1 (1%) |
Haemorrhagic stroke | 3 (2%) |
Peripheral ischemia of the leg requiring Surgery or intervention | 15 (9%) |
Haemolysis | 31 (19%) |
Bleeding (based on GUSTO definitions (25)) | |
Life-threatening/severe | 9 (5%) |
Moderate | 27 (16%) |
Mild | 33 (20%) |
Sepsis | 50 (30%) |
Renal replacement therapy | 84 (51%) |